Medical Crossfire®: Updates in Continuous Glucose Monitoring—Having the Important Conversations With Your Patients
Medical Crossfire®: Updates in Continuous Glucose Monitoring—Having the Important Conversations With Your Patients is organized by Physicians' Education Resource, LLC (PER).
Release Date: May 17, 2023
Expiration Date: May 17, 2024
Description:
Glycemic variability (GV) is associated with increased risk of hypoglycemia, vascular complications, and mortality in patients with diabetes mellitus (DM) independent of glycated hemoglobin level. Glycated hemoglobin does not address fluctuations in blood glucose. Continuous glucose monitoring (CGM) is becoming widely accepted as an adjunct to DM management. These technologies can provide detailed information about GV in an internationally standardized ambulatory glucose profile, enabling more informed user and clinician decision-making. By providing real-time information on glucose concentration and trends, CGM sensors have been shown to improve glycemic control, reduce hypoglycemia incidence, and decrease GV.
This online, on-demand symposium brings together renowned experts in the treatment of patients with diabetes mellitus. In this activity, 3 key opinion leaders explore the latest data regarding current and emerging therapeutic strategies for the use of CGM for patients with DM. This lively discussion places new developments into clinical context to help you optimize care for your patients with DM.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Describe the correlation between glycemic variability and poor cardiovascular outcomes in patients with diabetes mellitus (DM)
• Review clinical trial data for current and emerging continuous glucose monitoring (CGM) technologies and devices
• Incorporate CGM data using the ambulatory glucose profile to achieve targets established by the International Consensus on Time in Range in patients with DM.